Chris Haggerty

Biomedical scientist/engineer with a passion for translational cardiac research.

[Pierre Elias, MD @PierreEliasMD]

Want to know the state of AI & Cardiology? Our #JACC reviews are for you!
https://t.co/stDQG6sRby
Pt 1: The field's most comprehensive primer. Every study you should know about in 1 place
Pt 2: Tackling today's evidence, equity, & regulatory challenges
@EricTopol @mattlungrenMD

[Sneha Shah Jain, MD, MBA @SnehaShahJain]

🚀🫀Explore recent breakthroughs, future directions, and evaluation & infrastructure needs for #AI-augmented cardiovascular care. Learn more in our two-part review published in @JACCJournals #ACC24.

Part 1: https://t.co/Tz1l4B7MTY

Part 2: https://t.co/elZvG3l4v3

[Chris Haggerty @ChrisMHaggerty]

Awesome work - congrats @David_Ouyang and team

[David Ouyang, MD @David_Ouyang]

We are excited to announce that our blinded randomized clinical trial of AI LVEF (EchoNet-Dynamic) has been published in @nature! @bryandhe @james_y_zou @StanfordDBDS @CedarsSinaiMed

https://t.co/n7ntvPELUm

1/n

[Chris Haggerty @ChrisMHaggerty]

@vnparikh @StanfordDeptMed Sorry for being late to the party, but big congrats! Very well deserved!

[Michael Levin @MGLevin]

Excited to finally share the results of our GWAS and multi-trait analyses characterizing the 🧬 genetic architecture of 🫀heart failure, now published in @NatureComms

Thanks to @damrauer and @bvoight28 for their mentorship, and all the contributors!

https://t.co/uKx8g183s3

[Chris Haggerty @ChrisMHaggerty]

Awesome way to cap the first week! (Even if my team’s spaghetti structure didn’t quite get the job done..)

[Pierre Elias, MD @PierreEliasMD]

We got to welcome our new CRADLE teammates to NYC for an on-site! Bringing data scientists like @ChrisMHaggerty to @NYPAdvances and @ColumbiaMed, including our Cath lab & CCU. Started the day with which team could use spaghetti, string, and tape to make the tallest structure 😁

[Chris Haggerty @ChrisMHaggerty]

@jpirruccello @doctorveera In PA it’s a groundhog

[Chris Haggerty @ChrisMHaggerty]

This means today is my last day at Geisinger after almost 8 years. Tremendously grateful for my time here and the great colleagues I’ve had a chance to work with!

[Chris Haggerty @ChrisMHaggerty]

Some news: I’ll be starting Monday as Director of Data Science at NewYork-Presbyterian .. teaming up with @PierreEliasMD to accelerate development and implementation of machine learning in Cardiology across NYP, Columbia, and Cornell hospitals. Really excited for the road ahead..

[Chris Haggerty @ChrisMHaggerty]

Fantastic! Congrats Cindy! @Cynthia33573648

[Chris Haggerty @ChrisMHaggerty]

@MattHouliston @Biomaven @EricTopol @NatureMedicine @v_puntmann @GoetheCVI Agree, I think that is a strong hypothesis and worth looking into, especially for genes like TTN with strong evidence for a two-hit hypothesis. @EricCarruth3

[Pierre Elias, MD @PierreEliasMD]

Out today in @JACCJournals, our ValveNet study shows a ML model can detect mod-severe left sided valve disease from ECG. This model is currently running live in our health system daily. Now let me tell you everything wrong with it! A brief 🧵 https://t.co/rjtZxxTLt9

[Circulation: Genomic and Precision Medicine @Circ_Gen]

⚡️ From @ChrisMHaggerty + team: Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population https://t.co/R0ePHz3tLp

@AHAScience #AHAjournals

🎥 @AnwarChahal @jenniejlin

[Circulation @CircAHA]

#OriginalResearch: #rECHOmmend- an ECG-based machine-learning approach identifies patients at high-risk of undiagnosed structural heart-disease detectable by echocardiography @BrandonFornwalt @ChrisMHaggerty @_noahzim_ #AHAJournals https://t.co/Z7l0oEirFg

[Michael J. Ackerman MD,PhD @MJAckermanMDPhD]

So EXCITED to share that our (@AliveCor & @MayoClinic @MayoClinicCV) #ArtificialIntelligence-derived #QTc just received @US_FDA clearance. The QTc is now officially a readily obtainable, clinically actionable VITAL SIGN with life saving implications. @HRSonline #HRS2022 🤗

[Chris Haggerty @ChrisMHaggerty]

@ProtonotariosA @robyn_hylind Thanks for sharing! Look forward to seeing how UK Biobank findings compare to what we’ve observed in DiscovEHR/MyCode https://t.co/jKQzvLjho8

[Chris Haggerty @ChrisMHaggerty]

Great work looking at genetic correlations and outcomes in HFsnEF in UKB and BioME.

[Iain S. Forrest, MD-PhD @IainSForrest]

You’ve heard of HFrEF, HFmrEF and HFpEF… but have you heard of their sibling HFsnEF (heart failure + SUPRANORMAL EF)?
Our new study in @ESC_Journals https://t.co/nV1c9HC4ug sheds light on this understudied/underdiagnosed entity 🔎🫀

#CardioTwitter #CardioEd #MedTwitter
1/8

[Chris Haggerty @ChrisMHaggerty]

Awesome work, congrats team!

[Chris Haggerty @ChrisMHaggerty]

@pnatarajanmd @patrick_ellinor @GenPrecisionMed @MGHHeartHealth @mghcvrc @broadinstitute @AHAMeetings @AHAScience @Circ_Gen @harvardmed @American_Heart @bmprii @rosenzweig_a @MGHCVFellows Congrats!

[Chris Haggerty @ChrisMHaggerty]

Why wouldn’t it be both with TTN.. Occam’s Razor need not apply with that gene

[Ben Prosser @Prosser_Lab]

How do TTN mutations cause DCM? Haploinsufficiency? Poison Peptides? To date the evidence has been… well, neither. That changes now, with these side-by-side papers in @ScienceTM. 1/3 https://t.co/RfdfabjEdk